Abstract:Objective: To construct a neovessel-targeted PEGylated liposome formulation to promote the efficiency of the intracellular delivery of antitumor reagents. Methods: The complex of (alanyl-prolyl-arginyl-prolyl-glycine, APRPG) and (lysine-glycine-glycine, KGG) were synthesized by using fluorenylmethyloxycarbonyl ( FMOC) solid-phase synthesis method. The neovessel-targeted polyethylene glycol liposomes (T-PEG-LP) and polyethylene glycol-liposomes (PEG-LP) were prepared by thin film sonication-dispersion method. Mean particle size and particle size distribution of targeted PEGylated liposomes were determined using laser particle sizer. The morphology of liposomes was observed under transmission electron microscope (TEM). To evaluate the affinity between targeted liposomes and tumor cells or vessel endothelial cells, rhodamine-labelled neovessel targeted fluorescent polyethylene glycol liposomes ( T-F-PEG-LP) and fluorescent polyethylene glycol liposomes (F-PEG-LP) were synthesized by using thin film sonication-dispersion method. The specific binding of T-F-PEG-LP and F-PEG-LP with human umbilical vein endothelial cell ( HUVEC) and human lung cancer A549 cells was detected by fluorospectrophotometer examination and flow cytometry analysis. Polyethylene-glycol paclitaxel liposomes (PEG-PTX-LP) and neovessel-targeted polyethylene glycol paclitaxel liposomes (T-PEG-PTX-LP) were also prepared. The cellular uptakes of PEG-PTX-LP and T-PEG-PTX-LP by HUVEC and A549 cells were detected by fluorospectrophotometer examination and flow cytometry analysis. Results: TEM showed that both the T-PEG-LP PEG-LP shaped regular round or a little elliptic. Laser particle sizer indicated the average size of particles was less than 100 nm. T-F-PEG-LP had stronger affinity to HUVEC and A549 cells compared with F-PEG-LP(P<0.05). The uptakes of T-PTG-PTX-LP by HUVEC and A549 cells were higher than that of Taxol solusion and PEG-PTX-LP( P<0.05 ). Conclusion: The constructed formulation of neovessel-targeted PEGylated liposomes might be a novel effective carrier for anti-tumor reagents.

Enhanced Distribution and Anti-Tumor Activity of Ergosta-4,6,8(14),22-Tetraen-3-One by Polyethylene Glycol Liposomalization

Ergosterol-loaded Poly(lactide-Co-glycolide) Nanoparticles with Enhanced in Vitro Antitumor Activity and Oral Bioavailability

Ultra performance liquid chromatography coupled with electrospray and atmospheric pressure chemical ionization (ESCi)-quadrupole time-of-flight mass spectrometry with novel mass spectrometry(Elevated Energy) (MS(E)) data collection technique: determination and pharmacokinetics, tissue distribution a

Preparation of a novel neovessel-targeted PEGylated liposome formulation

Ergosta-4,6,8(14),22-tetraen-3-one induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells.

Folate-functionalized Nanoparticles for Controlled Ergosta-4,6,8(14),22-tetraen-3-one Delivery

Preparation of Folate-targeted Ergosta-4,6,8 (14), 22-tetraen-3-one Liposomes and Its Evaluation in Vitro and Pharmacokinetic Studies

Quantitative Hplc Method and Pharmacokinetic Studies of Ergosta-4,6,8(14),22-Tetraen-3-One, A Natural Product with Diuretic Activity from Polyporus Umbellatus

Research Progress on Pharmacology, Pharmacokinetics and Determination of Ergosta-4,6,8 (14), 22-Tetraen-3-one

Effect of Poly(ethylene Glycol) (PEG) Surface Density on the Fate and Antitumor Efficacy of Redox-Sensitive Hybrid Nanoparticles

A Comparison Study Between Lycobetaine-Loaded Nanoemulsion and Liposome Using Nrgd As Therapeutic Adjuvant for Lung Cancer Therapy

2-Naphthoic Acid Ergosterol Ester, an Ergosterol Derivative, Exhibits Anti-Tumor Activity by Promoting Apoptosis and Inhibiting Angiogenesis

Nanoemulsion loaded with lycobetaine-oleic acid ionic complex: physicochemical characteristics, in vitro, in vivo evaluation, and antitumor activity.

Mitochondrial targeted modification and anticancer mechanism of natural product ergosterol peroxide

Liposomes Co-Modified with Cholesterol Anchored Cleavable PEG and Octaarginines for Tumor Targeted Drug Delivery

PEGylated liposomes as delivery systems for Gambogenic acid: Characterization and in vitro/in vivo evaluation

Enhancement of Therapeutic Effectiveness by Combining Liposomal Honokiol with Cisplatin in Ovarian Carcinoma

Improving aqueous solubility and antitumor effects by nanosized gambogic acid-mPEG₂₀₀₀ micelles.

Improving plasma stability and antitumor effect of gemcitabine via PEGylated liposome prepared by active drug loading